Hormone replacement and the risk of breast cancer in Turner's syndrome

被引：32
作者：
Boesze, Peter [1 ]
Toth, Andras
Toeroek, Miklos
机构：
[1] St Stephen Hosp, H-1096 Budapest, Hungary
[2] Natl Hlth Ctr, H-1311 Budapest, Hungary
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 24期
关键词：
D O I：
10.1056/NEJMc062795
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2599 / 2600
页数：2
相关论文
共 4 条
  • [1] BOSZE P, 1979, OBSTET GYNECOL, V54, P544
  • [2] GAAL M, 1984, CLIN GENET, V25, P79
  • [3] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
    Rossouw, JE
    Anderson, GL
    Prentice, RL
    LaCroix, AZ
    Kooperberg, C
    Stefanick, ML
    Jackson, RD
    Beresford, SAA
    Howard, BV
    Johnson, KC
    Kotchen, JM
    Ockene, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 321 - 333
  • [4] Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the Women's Health Initiative
    Warren, Michelle P.
    Chua, Abigail
    [J]. GROWTH HORMONE & IGF RESEARCH, 2006, 16 : S98 - S102
1